H. Irving Pierce

1.5k total citations
22 papers, 834 citations indexed

About

H. Irving Pierce is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H. Irving Pierce has authored 22 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Genetics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H. Irving Pierce's work include Folate and B Vitamins Research (4 papers), Cancer Treatment and Pharmacology (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). H. Irving Pierce is often cited by papers focused on Folate and B Vitamins Research (4 papers), Cancer Treatment and Pharmacology (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). H. Irving Pierce collaborates with scholars based in United States. H. Irving Pierce's co-authors include Gary R. Morrow, Patrick J. Flynn, Richard F. Raubertas, Jeffrey J. Kirshner, Robert S. Hillman, Richard J. Rosenbluth, Kishan J. Pandya, Harry E. Hynes, Vladimir Dragalin and Edward R. Eichner and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

H. Irving Pierce

21 papers receiving 739 citations

Peers

H. Irving Pierce
Tarit K. Banerjee United States
Timothy L. McAuliffe United States
D Alexiou Greece
Stuart Campbell United Kingdom
Kathleen Flynn United States
Samuel J. Casella United States
Mary Woods United Kingdom
Tarit K. Banerjee United States
H. Irving Pierce
Citations per year, relative to H. Irving Pierce H. Irving Pierce (= 1×) peers Tarit K. Banerjee

Countries citing papers authored by H. Irving Pierce

Since Specialization
Citations

This map shows the geographic impact of H. Irving Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Irving Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Irving Pierce more than expected).

Fields of papers citing papers by H. Irving Pierce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Irving Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Irving Pierce. The network helps show where H. Irving Pierce may publish in the future.

Co-authorship network of co-authors of H. Irving Pierce

This figure shows the co-authorship network connecting the top 25 collaborators of H. Irving Pierce. A scholar is included among the top collaborators of H. Irving Pierce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Irving Pierce. H. Irving Pierce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fainberg, Jonathan, et al.. (2020). 144 Post-Orgasmic Illness Syndrome: A Case Report and Literature Review with Contemporary Treatment Considerations. The Journal of Sexual Medicine. 17(Supplement_1). S41–S42. 2 indexed citations
2.
Roscoe, Joseph A., Gary R. Morrow, Jane T. Hickok, et al.. (2003). The Efficacy of Acupressure and Acustimulation Wrist Bands for the Relief of Chemotherapy-Induced Nausea and Vomiting. Journal of Pain and Symptom Management. 26(2). 731–742. 93 indexed citations
3.
Pandya, Kishan J., Richard F. Raubertas, Patrick J. Flynn, et al.. (2000). Oral Clonidine in Postmenopausal Patients with Breast Cancer Experiencing Tamoxifen-Induced Hot Flashes: A University of Rochester Cancer Center Community Clinical Oncology Program Study. Annals of Internal Medicine. 132(10). 788–793. 209 indexed citations
4.
Ellis, Georgiana K., Stephanie Green, Robert B. Livingston, et al.. (1999). ‘Neo-FAC’ (5-Fluorouracil, Doxorubicin, and Cyclophosphamide) for Poor-Prognosis Stage IV Breast Cancer. American Journal of Clinical Oncology. 22(5). 446–446. 1 indexed citations
5.
Spiegel, David, Gary R. Morrow, Catherine Classen, et al.. (1999). Group psychotherapy for recently diagnosed breast cancer patients: a multicenter feasibility study. Psycho-Oncology. 8(6). 482–493. 127 indexed citations
6.
Ellis, Georgiana K., Julie R. Gralow, H. Irving Pierce, Margaret A. Williams, & R. B. Livingston. (1999). Infusional Paclitaxel and Weekly Vinorelbine Chemotherapy With Concurrent Filgrastim for Metastatic Breast Cancer: High Complete Response Rate in a Phase I-II Study of Doxorubicin-Treated Patients. Journal of Clinical Oncology. 17(5). 1407–1407. 26 indexed citations
7.
Strickland, C. June, Polly Feigl, David K. King, et al.. (1997). Improving Breast Self-Examination Compliance: A Southwest Oncology Group Randomized Trial of Three Interventions. Preventive Medicine. 26(3). 320–332. 24 indexed citations
8.
Spiegel, David, Gary R. Morrow, Catherine Classen, et al.. (1996). Effects of Group Therapy on Women with Primary Breast Cancer. The Breast Journal. 2(1). 104–106. 10 indexed citations
9.
Gupta, V. D., E. Brad Thompson, Donna Stock-Novack, et al.. (1994). Efficacy of prednisone in refractory multiple myeloma and measurement of glucocorticoid receptors. Investigational New Drugs. 12(2). 121–128. 10 indexed citations
10.
Zidar, Bernard L., et al.. (1992). A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A southwest oncology group study. Cancer. 70(10). 2547–2551. 34 indexed citations
11.
Weick, James K., Steve Dahlberg, Richard I. Fisher, et al.. (1991). Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: a Southwest Oncology Group study.. Journal of Clinical Oncology. 9(5). 748–753. 33 indexed citations
12.
Zidar, Bernard L., et al.. (1988). A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group Study. Investigational New Drugs. 6(3). 223–226. 70 indexed citations
13.
Dozy, A M, et al.. (1979). Alpha-thalassemia in blacks is due to gene deletion.. PubMed. 31(5). 569–73. 12 indexed citations
14.
Nute, Peter E., H. Irving Pierce, Mark A. Hermodson, J W Adamson, & G Stamatoyannopoulos. (1978). Environmental Modification of Gene Expression: Iron Deficiency Masks Erythrocytosis in a Female with Hemoglobin Olympia. Hemoglobin. 2(3). 275–279. 5 indexed citations
15.
Pierce, H. Irving, et al.. (1977). Frequencies of thalassemia in American blacks. Blood. 49(6). 981–986. 48 indexed citations
16.
Pierce, H. Irving. (1976). Clinical Studies in Alcoholic Sideroblastosis. Archives of Internal Medicine. 136(3). 283–283. 19 indexed citations
17.
Pierce, H. Irving & Robert S. Hillman. (1974). The Value of the Serum Vitamin B12 Level in Diagnosing B12 Deficiency. Blood. 43(6). 915–921. 14 indexed citations
18.
Pierce, H. Irving, et al.. (1974). Modifications in the purified rabbit skeletal muscle apophosphorylase-b assay of serum pyridoxal phosphate levels. Biochemical Medicine. 10(4). 360–367. 3 indexed citations
19.
Pierce, H. Irving. (1972). Meningococcal pericarditis. Clinical features andd therapy in five patients. Archives of Internal Medicine. 129(6). 918–922. 22 indexed citations
20.
Eichner, Edward R., H. Irving Pierce, & Robert S. Hillman. (1971). Folate Balance in Dietary-Induced Megaloblastic Anemia. New England Journal of Medicine. 284(17). 933–938. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026